Oscar Health (OSCR) Investor Day 2024 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2024 summary
1 Feb, 2026Strategic Vision and Business Model
Introduced a dynamic three-year strategic plan, updated annually to align with operational goals and market changes.
Mission centers on making a healthier life accessible and affordable for all, leveraging healthcare and technology expertise.
Four strategic objectives: achieve ~20% revenue CAGR and ~5% operating margin by 2027, enhance member experience, externalize technology, and expand the individual market with ICHRA.
Management compensation is tied to three-year EBIT targets, reinforcing accountability.
Committed to delivering innovative, culturally relevant plan designs and personalized experiences.
Market Positioning and Growth Strategy
Shifting focus from ACA to the broader individual market, leveraging a stable risk pool and expanding through ICHRA products.
Targeting entry into 150+ new MSAs by 2027 and building a leading ICHRA carrier business.
Plans to expand ACA market access from 50% to 70% by 2027, with further room for growth.
Growth pillars: disciplined footprint expansion, innovative products, and robust total cost of care management.
Positioned as a leading player in the fastest-growing health insurance market, with significant runway for technology monetization and ICHRA disruption.
Financial Guidance and Targets
Reaffirmed 2024 guidance: $8.3B–$8.4B revenue, 20.5%–21.0% SG&A ratio, 80.2%–81.2% MLR, and $125M–$175M Adjusted EBITDA.
Long-term targets: at least 20% revenue CAGR and 5% operating margin by 2027, assuming enhanced subsidies expire.
EPS expected to exceed $2.25 in 2027, with upside if subsidies are extended.
Achieved ~40% three-year membership CAGR and significant margin improvements; targeting Adjusted EBITDA profitability in 2024.
Capital allocation prioritizes organic growth, with strong excess capital and flexibility for optimization or potential share buybacks.
Latest events from Oscar Health
- Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Record 2025 revenue and membership, but higher costs led to a net loss; 2026 targets profitability.OSCR
Q4 202510 Feb 2026 - AI, personalization, and expanded financial tools are key to driving real healthcare consumerism.OSCR
7th Annual Healthcare Symposium3 Feb 2026 - Q2 revenue up 46%, net income $56.2M, membership up 63%, and full-year guidance raised.OSCR
Q2 20242 Feb 2026 - Reaffirmed guidance, robust growth outlook, and disciplined strategy set the stage for 2025.OSCR
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Strong growth, disciplined expansion, and AI-driven efficiency position for long-term outperformance.OSCR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - SEP-driven growth and disciplined pricing set up strong 2025 performance and long-term margin gains.OSCR
The Baird 2024 Global Healthcare Conference20 Jan 2026 - Q3 revenue rose 68% to $2.42B, with raised guidance and full-year profitability expected.OSCR
Q3 202416 Jan 2026 - First-ever annual net income and Adjusted EBITDA profitability achieved, with strong 2025 outlook.OSCR
Q4 20248 Jan 2026